Takeda Executive and Leadership Team

Nory Shiokawa, the Senior VP & Chief Financial Officer, Growth & Emerging Markets Business Unit at Takeda Pharmaceutical Company, directs financial planning and resource allocation across high-growth international territories. Shiokawa manages complex fiscal frameworks to support the expansion of pharmaceutical portfolios in emerging markets. By analyzing regional market trends, the Senior VP & Chief Financial Officer, Growth & Emerging Markets Business Unit optimizes capital deployment to ensure sustainable revenue growth. This leadership role involves close collaboration with regional heads to mitigate financial risks while maximizing the impact of plasma-derived therapies and vaccines. Nory Shiokawa maintains rigorous oversight of budgetary compliance, ensuring that all financial activities align with the broader corporate mission of delivering healthcare solutions. Through strategic fiscal management, Shiokawa secures the necessary funding to drive innovation in rare disease treatments, ultimately strengthening the competitive position of the organization within diverse global healthcare landscapes.

Gerardo Lazcano, the Director, Finance (Mexico) & Chief Financial Officer at Takeda Pharmaceutical Company, manages the fiscal health and financial reporting for regional operations. Lazcano oversees local financial planning, tax compliance, and investment strategies to support the distribution of pharmaceutical products. As the Director, Finance (Mexico) & Chief Financial Officer, Gerardo Lazcano ensures that regional financial activities remain consistent with global corporate standards. This role involves analyzing local market dynamics to optimize cost structures and improve profitability for the company's diverse healthcare offerings. By providing accurate financial forecasting, Lazcano enables leadership to make informed decisions regarding market expansion and product availability. The Director, Finance (Mexico) & Chief Financial Officer maintains a focus on operational efficiency, ensuring that the organization effectively navigates the economic complexities of the region while continuing to deliver essential medicines to patients in need of specialized care.

Milano Furuta, the Chief Financial Officer & Director at Takeda Pharmaceutical Company, directs the global financial strategy and corporate governance initiatives. Furuta oversees capital structure, financial reporting, and long-term investment planning to sustain the company's research and development efforts. As the Chief Financial Officer & Director, Milano Furuta ensures that the organization maintains a robust balance sheet capable of supporting innovation in neuroscience and rare diseases. This leadership role involves working closely with the Board to define fiscal priorities and ensure compliance with international financial regulations. By managing investor relations and corporate financial health, Furuta provides the stability required for the company to pursue its mission of delivering life-transforming therapies. The Chief Financial Officer & Director maintains a focus on sustainable growth, ensuring that financial resources are allocated effectively to maximize the impact of the company's pharmaceutical products on global health outcomes.

Allen Funk, the Global Category Manager & Associate Director & Chief Marketing Officer, Pharm Sci Large Molecule at Takeda Pharmaceutical Company, architects the commercial strategy for large molecule pharmaceutical products. Funk oversees the lifecycle management of complex biologics, ensuring that research breakthroughs translate into accessible patient solutions. As the Global Category Manager & Associate Director & Chief Marketing Officer, Pharm Sci Large Molecule, Allen Funk drives market penetration through data-driven promotional campaigns and strategic positioning. This role requires constant interaction with scientific teams to communicate the value of oncology and neuroscience innovations to healthcare providers. By aligning marketing initiatives with clinical data, Funk enhances the visibility of the company's specialized healthcare products. The Global Category Manager & Associate Director & Chief Marketing Officer, Pharm Sci Large Molecule maintains a focus on long-term brand equity, ensuring that the organization remains a leader in the competitive pharmaceutical sector through precise, evidence-based communication strategies.

Tracy Page, the Chief of Staff, Agile Operations Global Ethics & Compliance Head of Portfolio Management at Takeda Pharmaceutical Company, directs the integration of agile methodologies across global operations. Page ensures that all business processes adhere to the highest standards of ethics and compliance while managing the company's extensive pharmaceutical portfolio. As the Chief of Staff, Agile Operations Global Ethics & Compliance Head of Portfolio Management, Tracy Page optimizes operational workflows to accelerate the development of gastroenterology and rare disease treatments. This leadership position involves coordinating cross-functional teams to streamline decision-making and resource prioritization. By fostering a culture of transparency and efficiency, Page supports the organization in navigating complex regulatory environments. The Chief of Staff, Agile Operations Global Ethics & Compliance Head of Portfolio Management maintains a focus on long-term strategic alignment, ensuring that every project contributes directly to the overarching goal of improving patient outcomes through disciplined, ethical, and agile management practices.

Jessica Vieira, the Global Supply & Quality Chief of Staff at Takeda Pharmaceutical Company, directs the coordination of supply chain logistics and quality assurance protocols. Vieira ensures that the manufacturing and distribution of pharmaceutical products meet stringent global safety and efficacy standards. As the Global Supply & Quality Chief of Staff, Jessica Vieira optimizes the flow of materials and finished goods to maintain consistent product availability for patients worldwide. This role involves managing cross-functional communication between manufacturing sites and quality control teams to resolve operational bottlenecks. By implementing rigorous quality management systems, Vieira safeguards the integrity of the company's gastroenterology and oncology treatments. The Global Supply & Quality Chief of Staff maintains a focus on operational excellence, ensuring that the supply chain remains resilient and responsive to the evolving needs of the global healthcare market while upholding the highest standards of product quality.

Colleen Beauregard, the Vice President and Chief of Staff, Global Research and Development at Takeda Pharmaceutical Company, directs the operational strategy for the company's extensive R&D pipeline. Beauregard coordinates the efforts of scientific teams to advance the development of innovative therapies in neuroscience and rare diseases. As the Vice President and Chief of Staff, Global Research and Development, Colleen Beauregard ensures that research initiatives align with the company's long-term clinical goals and market needs. This leadership role involves managing the R&D budget, overseeing project timelines, and facilitating collaboration between internal researchers and external partners. By streamlining the drug discovery process, Beauregard accelerates the transition of promising compounds from the laboratory to clinical trials. The Vice President and Chief of Staff, Global Research and Development maintains a focus on scientific excellence, ensuring that the organization continues to push the boundaries of medical innovation to address unmet patient needs.

Lindsay Gotts, the Chief of Staff Transformation Lead at Takeda Pharmaceutical Company, directs large-scale organizational change initiatives to improve operational efficiency. Gotts oversees the implementation of new business models and digital tools designed to modernize the company's pharmaceutical operations. As the Chief of Staff Transformation Lead, Lindsay Gotts facilitates the transition toward more agile and data-driven workflows across all departments. This role involves identifying areas for process improvement and leading cross-functional teams to execute strategic transformation projects. By fostering a culture of continuous improvement, Gotts ensures that the organization remains adaptable in a rapidly changing healthcare landscape. The Chief of Staff Transformation Lead maintains a focus on long-term organizational health, ensuring that internal structures support the company's mission of delivering high-quality healthcare products while maintaining a competitive edge through innovation and operational agility.

Swarup Shetty, the Director, Business Excellence & Global Regulatory Operations Chief of Staff at Takeda Pharmaceutical Company, directs the integration of business excellence frameworks with global regulatory compliance. Shetty oversees the standardization of regulatory processes to ensure that all pharmaceutical products meet international safety and efficacy requirements. As the Director, Business Excellence & Global Regulatory Operations Chief of Staff, Swarup Shetty optimizes the submission and approval workflows for new therapies. This leadership role involves coordinating with regulatory agencies and internal teams to ensure timely market access for the company's gastroenterology and rare disease treatments. By implementing best practices in regulatory operations, Shetty reduces complexity and enhances the efficiency of the drug approval process. The Director, Business Excellence & Global Regulatory Operations Chief of Staff maintains a focus on compliance and quality, ensuring that the organization consistently meets the rigorous demands of global health authorities.

Julian Harrison, the Global Chief of Staff, Legal at Takeda Pharmaceutical Company, directs the operational strategy for the legal department. Harrison oversees the management of legal resources and ensures that all corporate activities align with international law and ethical standards. As the Global Chief of Staff, Legal, Julian Harrison facilitates communication between legal counsel and executive leadership to address complex business challenges. This role involves managing the legal department's budget, overseeing contract administration, and supporting the protection of the company's intellectual property. By providing strategic legal guidance, Harrison enables the organization to navigate the complexities of the global pharmaceutical market with confidence. The Global Chief of Staff, Legal maintains a focus on risk mitigation and corporate integrity, ensuring that all business operations are conducted in accordance with the highest legal and ethical standards, thereby supporting the company's mission of delivering life-transforming therapies.